SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Ask Vendit Off-Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (5573)2/28/2005 2:43:20 PM
From: MJ  Read Replies (1) | Respond to of 8752
 
They sure did take a big hit on this. This is a prime example of how difficult it is to "hold" a stock in the biotechs/pharmac. area.

Elan went from around 27 to where it is now 8.00 plus a few cents in three days.

Terry, would the chart of Elan have predicted this slide a week ago or several weeks ago?

I ask the question so that a charting lesson can be learned if there is one to learn here.

mj



To: Walkingshadow who wrote (5573)2/28/2005 5:48:56 PM
From: Jill  Read Replies (3) | Respond to of 8752
 
This whole idea of blocking inflammatory pathways is misguided imo. Period. We need inflammation in order to fight pathogens. It would be better if they found the viral/bacterial source of diseases like MS and treated the cause not the symptoms. Same for Cox-2 inhibitors although chronic pain is something that may be worth the risk of nothing else works, but those were way too widely prescribed.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News